Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · June 02, 2015

Oral Nicotinamide Is Safe and Effective in Reducing Actinic Cancer

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Oral Nicotinamide to Reduce Actinic Cancer: A Phase 3 Double-Blind Randomized Controlled Trial
J. Clin. Oncol 2015 May 01;[EPub Ahead of Print], AJ Martin, A Chen, B Choy, PF Penas, G Halliday, R Dalziell, C McKenzie, RA Scolyer, HM Dhillon, JL Vardy, G St George, N Chinniah, D Damian

Further Reading